SCHLUMBERGER LTD (SLB)       51.38  -1.41 (-2.67%)

51.38  -1.41 (-2.67%)

AN8068571086 - Common Stock - Premarket: 50.45 -0.93 (-1.81%)


Fundamental Rating

6

Taking everything into account, SLB scores 6 out of 10 in our fundamental rating. SLB was compared to 91 industry peers in the Energy Equipment & Services industry. While SLB has a great profitability rating, there are some minor concerns on its financial health. SLB is valued quite expensive, but it does show an excellent growth.




Profitability

Profitability Rating

9

SLB has a Return On Assets of 6.75%. This is amongst the best returns in the industry. The industry average is -1.04%. SLB outperforms 82% of its industry peers.
SLB has a Return On Equity of 17.31%. This is better than the industry average of 10.86%.

SLB has a Profit Margin of 11.26%. This is amongst the best returns in the industry. The industry average is -0.19%. SLB outperforms 89% of its industry peers.
The Piotroski-F score of SLB is 8.00. This is a very strong score and indicates great health and profitability for SLB.
VS Industry

ROA (6.75%) VS Industry: 82% outperformed.

-226.86
42,190.18

ROE (17.31%) VS Industry: 70% outperformed.

0.23
39.13

Profit Margin (11.26%) VS Industry: 89% outperformed.

-95.78
67,560.47

Valuation

Valuation Rating

3

The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
With a Forward Price/Earnings Ratio of 18.15, SLB is valued rather expensively.
When comparing the current price to the book value of SLB, we can conclude it is valued correctly. It is trading at 4.24 times its book value.
The Price/Earnings Ratio is 27.33, which means the current valuation is very expensive for SLB.

Compared to an average industry Price/Earning Ratio of 21.40, SLB is valued slightly more expensive.
When comparing the price book ratio of SLB to the average industry price book ratio of 1.37, SLB is valued more expensive than its industry peers. 87% of the companies listed in the same industry are valued cheaper.
When comparing the Enterprise Value to EBITDA ratio of SLB to the average industry ratio of 9.29, SLB is valued more expensive than its industry peers. 82% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (27.33) VS Industry: 38% outperformed.

471.90
0.05

Price/Book (4.24) VS Industry: 13% outperformed.

10.20
0.21

Enterprise Value/ EBITDA (13.66) VS Industry: 18% outperformed.

255.74
1.55

Growth

Growth Rating

7

SLB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.48%, which is quite impressive.
The Earnings Per Share is expected to grow by 35.31% on average over the next 5 years. This is a very strong growth
The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
Looking at the last year, SLB shows a quite strong growth in Revenue. The Revenue has grown by 18.89% in the last year.

The Revenue is expected to grow by 11.42% on average over the next 5 years. This is quite good.
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.
The Earnings Per Share has been growing slightly by 2.17% on average over the past 5 years.
The Revenue has been decreasing by -3.79% on average over the past 5 years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS2.17% -7.74% 72.48% 59.75% 48.73% 39.25% 35.31%
Revenue-3.79% -11.26% 18.89% 22.93% 19.46% 16.25% 11.42%

Health

Health Rating

5

The Altman-Z score of SLB is much better than the industry average of 1.62.
The Piotroski-F score of SLB is 8.00. This is a very strong score and indicates great health and profitability for SLB.
SLB has a Current Ratio of 1.40. This is a normal value and indicates that SLB is financially healthy and should not expect problems in meeting its short term obligations.
SLB has a Quick Ratio of 1.03. This is a normal value and indicates that SLB is financially healthy and should not expect problems in meeting its short term obligations.

An Altman-Z score of 2.98 indicates that SLB is not a great score, but indicates only limited risk for bankruptcy at the moment.
When comparing the Current Ratio of SLB to the average industry Current Ratio of 1.78, SLB is less able to pay its short term obligations than its industry peers.
Compared to an average industry Quick Ratio of 1.37, SLB is worse placed to pay its short term obligations than its industry peers. 82% of its industry peers have a better Quick Ratio.
When comparing the Debt to Equity Ratio of SLB to the average industry Debt to Equity Ratio of 0.39, SLB required more debt to finance its operations than its industry peers.
VS Industry

Debt/Equity (0.72) VS Industry: 30% outperformed.

5.89
0.00

Quick Ratio (1.03) VS Industry: 18% outperformed.

0.12
8.05

Current Ratio (1.4) VS Industry: 26% outperformed.

0.12
8.35

Altman-Z (2.98) VS Industry: 75% outperformed.

-2,347.49
37.50

Dividend

Dividend Rating

4

26.03% of the earnings are spent on dividend by SLB. This is a low number and sustainable payout ratio.
SLB has paid a dividend for at least 10 years, which is a reliable track record.
SLB has a Yearly Dividend Yield of 1.38%.

SLB's Dividend Yield is slightly below the industry average, which is at 1.98.
Compared to an average S&P500 Dividend Yield of 2.43, SLB's dividend is way lower than the S&P500 average.
The dividend of SLB decreases each year by -41.52%.
VS Industry

Dividend Yield (1.38%) VS Industry: 32% outperformed.

0.19
11.44
SLB Daily chart

SCHLUMBERGER LTD51.38

NYSE:SLB (12/5/2022, 9:00:14 PM)-1.41 (-2.67%)

Premarket: 50.45 -0.93 (-1.81%)

Chartmill FA Rating
GICS Sector Energy
GICS IndustryGroup Energy
GICS Industry Energy Equipment & Services
Earnings (Last) 10-21 2022-10-21/bmo Earnings (Next) 01-19 2023-01-19
Ins Owners 0.18% Inst Owners 82.46%
Market Cap 72.86B Analysts 83.64
Valuation
PE 27.33 Fwd PE 18.15
PEG (NY) 0.46 PEG (5Y) 12.62
P/S 2.76 P/B 4.24
EV/EBITDA 13.66
Dividend
Dividend Yield 1.38% Dividend Growth -41.52%
DP 26.03% Ex-Date 09-06 2022-09-06 (0.175)
Growth
EPS 1Y 72.48% EPS 3Y -7.74%
EPS 5Y 2.17% EPS growth Q2Q 75%
EPS Next Y 59.75% EPS Next 2Y 48.73%
EPS Next 3Y 39.25% EPS Next 5Y 35.31%
Revenue growth 1Y 18.89% Revenue growth 3Y -11.26%
Revenue growth 5Y -3.79% Revenue growth Q2Q 27.88%
Revenue Next Year 22.93% Revenue Next 2Y 19.46%
Revenue Next 3Y 16.25% Revenue Next 5Y 11.42%
Health
Current Ratio 1.4 Quick Ratio 1.03
Altman-Z 2.98 F-Score 8
Debt/Equity 0.72 WACC 11.41%
ROIC/WACC 2.71
Profitability
ROA 6.75% ROE 17.31%
ROICexgc 30.89% ROIC 9.1%
PM 11.26% OM 13.97%
Asset Turnover 0.6

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA